A group of immune proteins called the inflammasome can help prevent blood stem cells from becoming malignant by removing ...

A little-known mouse protein disrupts cancer-causing chemical changes to genes associated with human colorectal cancer cells ...

The most important take-home information from the INTERLACE trial is that in some people with cervical cancer that are ...

Microbeam radiation therapy has proven effective in animal studies against tumours in the brain, breast, skin and central ...

Researchers at Case Western Reserve University School of Medicine have discovered how specific protein regions contribute to breast cancer.

A research team at Memorial Sloan Kettering Cancer Center (MSK) has made new insights into how the body forms immune cell ...

US-based Normunity has raised $75m in a Series B funding round to support the clinical development of its lead programme, NRM-823, a potential first-in-class T-cell engager (TCE) targeting solid ...

A new therapy for the most aggressive type of brain cancer can extend patients' survival while cutting the length of ...

Inc. (NYSE American: CLDI) (“Calidi”), a clinical-stage biotechnology company developing a new generation of targeted antitumor virotherapies, today announced that its abstract, titled "Development of ...

A groundbreaking study from Baylor College of Medicine explores how two types of CAR T cells target cancer, shedding light on ...

Thanks to an innovative method of super-resolution microscopy, researchers observed with molecular resolution in 3D how therapeutic antibodies attack and alter B cells, thereby inducing their ...

Professor Markus Sauer from the Biocentre of Julius-Maximilians-Universität (JMU) Würzburg in Bavaria, Germany ...